Hope you all are well! NEW blog alert! Overview of #DataSharing and #DataManagement Practices and the considerations for #clinicaltrials ! Take a peek at guidance, global policies and #bestpractices! Stop by the Life Sciences Hub to explore links to #datarepositories ! #SuccessTips #ResearchStrategy #ClinicalTrials#LifeSciences #ClinicalTrials #GCP #RegulatoryAffairs #Ethics #ClinicalResearch #HealthcareInnovation #Pharma #Biotech #ResearchCommunity #ClinicalOperations #DrugDevelopment #MedicalResearch #ClinicalData #ResearchExcellence #ClinicalPractice #ScientificInnovation #HealthTech #culturalvigilance #inclusion #medtech #dataanalysis #commondataelements #fairshare #dataprivacy #dataintegrity https://lnkd.in/gWFpcBm7
New blog alert on DataSharing and DataManagement
More Relevant Posts
-
If you want to learn more about #synthetic data and the value delivered to Pharma and CROs, join our webinar tomorrow. InSilicoTrials, Simmons & Simmons , IBSA Group , Premier Research
Join me on Thursday 11 April at 10.30-11.30am CEST / 9.30-10.30am BST for our Simmons & Simmons webinar on "The synthetic data revolution in healthcare: ethics, derisking and patient-centered outcomes". My colleague Lydia Torne and I will be joined by industry experts Lucia Zaccardi, Raphaela Schnurbus and Mario Torchia, who will discuss their respective experience using synthetic data in developing new medicines. Register here: https://lnkd.in/eUZ5PnKz #syntheticdata #lifesciences #digitalhealth
To view or add a comment, sign in
-
Explore the ethical challenges and multidisciplinary perspectives on drug shortages, with a focus on creating a shared ethical framework. 📖 Read the full paper here: https://lnkd.in/gmjh4jFa Authors: Maya C. Wai #DrugShortage #EthicsInPharmacy #MultidisciplinaryApproach #PharmacyResearch
To view or add a comment, sign in
-
✨ Running a clinical trial doesn’t have to be overwhelming. With AstraCure Solutions, you get: ✔ Seamless study execution ✔ Expert data analysis ✔ Publication-ready results ✔ Comprehensive support, every step of the way 📊 Focus on your research while we handle the complexities! DM us to learn how we can help. #ClinicalTrials #CRO #MedicalResearch #LifeScience #DataAnalysis #AstraCureSolutions #biostatistics #clinicalresearch #clinicalresearchassociate #clinicalresearchcoordinator #clinicaltrials #clinical #clinicalresearchjobs #clinicalresearchcareers #clinicalresearchtrials #clinicalresearchers #clinicalresearchstudy #clinicalresearchassociates #clinicalresearchprofessionals #ethics #ethicscommittee #ethicscommitteemeeting #ethicscommitteereport #biostatistician #dataanalytics #datamanagement #datamanagementandbiostatistic #quality #qualitycheck #qualityassurance
To view or add a comment, sign in
-
-
Clinical research is the backbone of medical innovation...but how do we rebuild trust when misinformation clouds public perception? In our latest blog, one of our clinical research associates, Natalie Watkins, MS, shares her insights on the challenges of misinformation, the importance of ethical standards, and actionable steps to strengthen trust in the clinical research process. Whether you’re in the industry or just curious, this is a conversation worth having. 🗣️ https://lnkd.in/dapaMftC What do you think is the most effective way to combat misinformation in clinical research? #ClinicalResearch #Ethics #Innovation #CovarsaDx #Misinformation #GoodClinicalPractices #CRO #IVD #MedicalDevices #MedTech
To view or add a comment, sign in
-
-
What does “good” representation in clinical trials look like? https://bit.ly/418pu4y To answer that question, Jennifer E. Miller and her team at Bioethics International devised a one-of-a-kind scoring system. Find out what goes into that score in Part 2 of our conversation with her. #ClinicalTrials #ClinicalEquality
To view or add a comment, sign in
-
-
I'm optimistic about AI's use in developing new drugs and medical devices and even creating efficiencies in clinical trial conduct. However, now is the time to review the foundations of patient protection in the regulatory processes that govern these activities with a lens on the potential impacts of these innovations. Reviewing the new amendments to the Declaration of Helsinki, which is just out this week, is an excellent place to start. Listen to Dr. Jack Resnick, Process Chair for the World Health Organization's working group, discuss developing the amendments in the podcast below. #bioethics #patientprotections #communityengagement #clinicaltrials #regulatory affairs
To view or add a comment, sign in
-
🔍 Join the Conversation: MRCT Center’s Bioethics Collaborative The Multi-Regional Clinical Trials Center of Brigham and Women's Hospital and Harvard (MRCT Center) Bioethics Collaborative provides a unique platform for robust discussions on the ethical challenges surrounding clinical trials and global research. It’s an open space for sponsors and experts from diverse fields to come together to address pressing ethical issues and share best practices for improving research integrity and participant protection. As an example, the June 2024 meeting focused on reciprocity in research and its role in ensuring justice for host communities in resource-limited settings. Participants explored: · Ethical strategies to ensure fair distribution of benefits to host communities involved in research. · Key frameworks like reasonable availability, fair benefits, and the human development approach to address potential exploitation. · The need for capacity building and transparent benefit-sharing agreements to build trust in research partnerships. These thought-provoking discussions help shape the future of ethical clinical research. Interested in joining this forum? Learn how to become a part of the MRCT Center’s Bioethics Collaborative here: https://bit.ly/48dd90v #Bioethics #ClinicalResearch #ResearchEthics #JusticeInResearch #GlobalHealth
To view or add a comment, sign in
-
Take a look back at #HAC2024 with Antoine Ferrère! 🩺 Last September, we had the privilege of hosting Antoine Ferrere at The Human Advantage Conference, where he shared his expertise as Global Head of Behavioral and Data Science, Ethics, Risks & Compliance at Novartis. During the roundtable discussion titled "𝐿𝑒𝑣𝑒𝑟𝑎𝑔𝑖𝑛𝑔 𝐵𝑒ℎ𝑎𝑣𝑖𝑜𝑟𝑎𝑙 𝑆𝑐𝑖𝑒𝑛𝑐𝑒 𝑓𝑜𝑟 𝐻𝑅 𝐸𝑥𝑐𝑒𝑙𝑙𝑒𝑛𝑐𝑒: 𝑇𝑟𝑎𝑛𝑠𝑓𝑜𝑟𝑚𝑖𝑛𝑔 𝑇𝑒𝑎𝑚𝑠, 𝐶𝑢𝑙𝑡𝑖𝑣𝑎𝑡𝑖𝑛𝑔 𝑉𝑎𝑙𝑢𝑒𝑠, 𝑎𝑛𝑑 𝐸𝑛𝑠𝑢𝑟𝑖𝑛𝑔 𝑃𝑠𝑦𝑐ℎ𝑜𝑙𝑜𝑔𝑖𝑐𝑎𝑙 𝑆𝑎𝑓𝑒𝑡𝑦," Antoine highlighted how #behavioralsciences can assist pharmaceutical companies in promoting positive #behaviors towards #medications on the market. 🧠❤ In this interview, Antoine stresses the significance of considering social and behavioral sciences, alongside medical and technical aspects, to facilitate the adoption of medications and reduce skepticism about them. Share your thoughts in the comments, and read more about Antoine's roundtable speech with Dana Vigier, MD and Jean-Christophe Barland in our article 👉 https://lnkd.in/e6ZDnqAz CC | Eric Singler | Ted Utoft | Emilie Boutes | Isabelle LE | Tiphaine Breton
To view or add a comment, sign in
-
Ethical concerns are significant in developing medical devices. As this industry progresses, questions about patient safety, privacy, and fair access arise. Our latest article discusses the key ethical issues developers must address to ensure medical devices help everyone while maintaining high moral standards. You can read the complete discussion on our website. Blog: https://lnkd.in/gjh2JUtv #medicaldevices #bioethics #healthcareinnovation #patientcare #ethicalresearch #biotechnologynews #lifesciences
To view or add a comment, sign in
-
-
With so many of the clients I speak to starting to understand the importance of involving patients as early as possible in the drug development process - can behavioural science facilitate this? The Alpharmaxim team wholeheartedly say 'YES!' If you're interested in finding out how - get in touch (and do watch the video in the post below - well worth a listen!)
Is it time to incorporate behavioural science into early drug design and development? Outsourcing-Pharma’s Senior Editor Liza Laws caught up with Alpharmaxim founder and behavioural science advocate William Hind and SSI Strategy's Lisa Campbell to discuss the pursuit of a truly patient-focused approach from day one. https://lnkd.in/d_ezCp4T
To view or add a comment, sign in
-